SC Taylor .2003 .Epidemiology of skin diseases in ethnic populations. Dermatolhand Clin, 21(4) : 601-7.
Handel AC,Miot LDB,Miot HA .2014 .Melasma: a clinical and epidemiological review. An Bras Dermatol, 89 : 771-82.
Handel A,Lima P,Tonolli V,Miot L,Miot HA .2014 .Risk factors for facial melasma in women: a case-control study. Br J Dermatol, 171(3) : 588-94.
Berardesca E,Rigoni C,Cantù A,Cameli N,Tedeschi A,Italia DD .2020 .Effectiveness of a new cosmetic treatment for melasma. J Cosmet Dermatol, 19(7) : 1684-90.
Ogbechie-Godec OA,Elbuluk N. .2017 .Melasma: an up-to-date comprehensive review. Dermatol Ther, 7(3) : 305-18.
Kim HJ,Moon SH,Cho SH,Lee JD .2017 .Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review. Acta Dermato-Venereol, 97(6-7) : 776-81.
Sarma N,Chakraborty S,Poojary SA,Rathi S,Kumaran S,Nirmal B .2017 .Evidencebased Review, Grade of Recommendation, and Suggested Treatment Recommendations for Melasma. Indian Dermatol Online J, 8(6) : 406-42.
Zaky MS,Obaid ZM,Khalil EA,Elsaie ML .2021 .Microneedling‐assisted topical tranexamic acid solution versus 4% hydroquinone for treating melasma: A split‐face randomized study. J Cosmet Dermatol, 20(12) : 4011-6.
Tehranchinia Z,Saghi B,Rahimi H .2018 .Evaluation of therapeutic efficacy and safety of tranexamic acid local infiltration in combination with topical 4% hydroquinone cream compared to topical 4% hydroquinone cream alone in patients with melasma: a split-face study. Dermatol Res Practge, 2 : 1-5.
Gheisari M,Dadkhahfar S,Olamaei E,Moghimi HR,Niknejad N,Najar Nobari N. .2020 .The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: A randomized controlled trial. J Cosmet Dermatol, 19(1) : 167-72.
Mapar MA,Hemmati AA,Namdari G .2019 .Comparing the Efficacy of Topical Metformin and Placebo in the Treatment of Melasma: A Randomized, Double-blind, Clinical Trial. J Pharm Res Int, 30(4) : 1-8.
Banavase Channakeshavaiah R .2020 .Topical metformin in the treatment of melasma: A preliminary clinical trial. J Cosmet Dermatol, 19(5) : 1161-4.
Belisle ES,Park H-Y. Metformin ES .2014 .A potential drug to treat hyperpigmentation disorders. J Investig Dermatol, 134(10) : 2488-91.
Batchuluun B,Inoguchi T,Sonoda N,Sasaki S,Inoue T,Fujimura Y .2014 .Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD (P) H oxidase pathway in human aortic endothelial cells. Atherosclerosis, 232(1) : 156-64.
Bubna AK .2016 .Metformin- For the dermatologist. Indian J Pharmacol, 48(1) : 4-10.
Banavase Channakeshavaiah R .2020 .Topical metformin in the treatment of melasma: A preliminary clinical trial. J Cosmet Dermatol, 19(5) : 1161-4.
Nofal A,Ibrahim ASM,Nofal E,Gamal N,Osman S. .2019 .Topical silymarin versus hydroquinone in the treatment of melasma: A comparative study. J Cosmet Dermatol, 18(1) : 263-70.
Lehraiki A,Abbe P,Cerezo M,Rouaud F,Regazzetti C,Chignon-Sicard B .2014 .Inhibition of melanogenesis by the antidiabetic metformin. J Invest Dermatol, 134(10) : 2589-97.
AboAlsoud ES,Eldahshan RM,AbouKhodair Mohammed H,Elsaie ML .2022 .Safety and efficacy of topical metformin 30% cream versus triple combination cream (Kligman's formula) in treating melasma: A randomized controlled study. J Cosmet Dermatol, 21(6) : 2508-15.
Shokier DAEA,Mohamed HF,Badria FAER .2023 .. Is Topical Metformin Effective in Treatment of Melasma? Egypt J Hosp Med, 90(1) : 1407-12.
Achar A,Rathi SK .2011 .Melasma: a clinicoepidemiological study of 312 cases. , 56(4) : 380.
Sheth VM,Pandya AG .2011 .Melasma: a comprehensive update: part II. J Am Acad Dermatol, 65(4) : 699-714.
Duteil L,Cardot‐Leccia N,Queille‐Roussel C,Maubert Y,Harmelin Y,Boukari F .2014 .Differences in visible light‐induced pigmentation according to wavelengths: a clinical and histological study in comparison with UVB exposure. Pigment Cell Melanoma Res, 27(5) : 822-6.